Search

Your search keyword '"Santin, Alessandro"' showing total 408 results
Start Over Author "Santin, Alessandro" Search Limiters Peer Reviewed
408 results on '"Santin, Alessandro"'

1. Trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody–drug conjugate, demonstrates in vitro and in vivo antitumor activity against primary and metastatic ovarian tumors overexpressing HER2

Author

Mutlu, Levent, McNamara, Blair, Bellone, Stefania, Manavella, Diego D., Demirkiran, Cem, Greenman, Michelle, Verzosa, Miguel Skyler Z., Buza, Natalia, Hui, Pei, Hartwich, Tobias Max Philipp, Harold, Justin, Yang-Hartwich, Yang, Zipponi, Margherita, Altwerger, Gary, Ratner, Elena, Huang, Gloria S., Clark, Mitchell, Andikyan, Vaagn, Azodi, Masoud, Schwartz, Peter E., and Santin, Alessandro D.

Published
2024
Full Text
View/download PDF

7. Molecular determinants of clinical outcomes of pembrolizumab in recurrent ovarian cancer: Exploratory analysis of KEYNOTE-100

Author

Ledermann, Jonathan A., Shapira-Frommer, Ronnie, Santin, Alessandro D., Lisyanskaya, Alla S., Pignata, Sandro, Vergote, Ignace, Raspagliesi, Francesco, Sonke, Gabe S., Birrer, Michael, Provencher, Diane M., Sehouli, Jalid, Colombo, Nicoletta, González-Martín, Antonio, Oaknin, Ana, Ottevanger, P.B., Rudaitis, Vilius, Kobie, Julie, Nebozhyn, Michael, Edmondson, Mackenzie, Sun, Yuan, Cristescu, Razvan, Jelinic, Petar, Keefe, Stephen M., and Matulonis, Ursula A.

Published
2023
Full Text
View/download PDF

8. Health-Related Quality of Life in Patients With Advanced Endometrial Cancer Treated With Lenvatinib Plus Pembrolizumab or Treatment of Physician’s Choice

Author

Lorusso, Domenica, Colombo, Nicoletta, Herraez, Antonio Casado, Santin, Alessandro D., Colomba, Emeline, Miller, David Scott, Fujiwara, Keiichi, Pignata, Sandro, Baron-Hay, Sally E., Ray-Coquard, Isabelle Laure, Shapira-Frommer, Ronnie, Kim, Yong Man, McCormack, Mary, Massaad, Rachid, Nguyen, Allison Martin, Zhao, Qi, McKenzie, Jodi, Prabhu, Vimalanand S., and Makker, Vicky

Published
2023
Full Text
View/download PDF

9. Uterine leiomyosarcomas harboring MAP2K4 gene amplification are sensitive in vivo to PLX8725, a novel MAP2K4 inhibitor

Author

McNamara, Blair, Harold, Justin, Manavella, Diego, Bellone, Stefania, Mutlu, Levent, Hartwich, Tobias Max Philipp, Zipponi, Margherita, Yang-Hartwich, Yang, Demirkiran, Cem, Verzosa, Miguel Skyler Z., Yang, Kevin, Choi, Jungmin, Dong, Weilai, Buza, Natalia, Hui, Pei, Altwerger, Gary, Huang, Gloria S., Andikyan, Vaagn, Clark, Mitchell, Ratner, Elena, Azodi, Masoud, Schwartz, Peter E., Burton, Elizabeth A., Inagaki, Hiroaki, Albers, Aaron, Zhang, Chao, Bollag, Gideon, Schlessinger, Joseph, and Santin, Alessandro D.

Published
2023
Full Text
View/download PDF

10. Mismatch repair deficiency, next-generation sequencing-based microsatellite instability, and tumor mutational burden as predictive biomarkers for immune checkpoint inhibitor effectiveness in frontline treatment of advanced stage endometrial cancer

Author

Hill, Breana L, Graf, Ryon P, Shah, Kunal, Danziger, Natalie, Lin, Douglas I, Quintanilha, Julia, Li, Gerald, Haberberger, James, Ross, Jeffrey S, Santin, Alessandro D, Slomovitz, Brian, Elvin, Julia A, and Eskander, Ramez N

Published
2023
Full Text
View/download PDF

11. Safety and activity of anti-mesothelin antibody–drug conjugate anetumab ravtansine in combination with pegylated-liposomal doxorubicin in platinum-resistant ovarian cancer: multicenter, phase Ib dose escalation and expansion study

Author

Santin, Alessandro D, Vergote, Ignace, González-Martín, Antonio, Moore, Kathleen, Oaknin, Ana, Romero, Ignacio, Diab, Sami, Copeland, Larry J, Monk, Bradley J, Coleman, Robert L, Herzog, Thomas J, Siegel, Jonathan, Kasten, Linda, Schlicker, Andreas, Schulz, Anke, Köchert, Karl, Walter, Annette O, Childs, Barrett H, Elbi, Cem, and Bulat, Iurie

Published
2023
Full Text
View/download PDF

12. The Poly (ADP-ribose) polymerase inhibitor olaparib and pan-ErbB inhibitor neratinib are highly synergistic in HER2 overexpressing epithelial ovarian carcinoma in vitro and in vivo

Author

Han, Chanhee, McNamara, Blair, Bellone, Stefania, Harold, Justin, Manara, Paola, Hartwich, Tobias Max Philipp, Mutlu, Levent, Yang-Hartwich, Yang, Zipponi, Margherita, Demirkiran, Cem, Verzosa, Miguel Skyler Z., Altwerger, Gary, Ratner, Elena, Huang, Gloria S., Clark, Mitchell, Andikyan, Vaagn, Azodi, Masoud, Dottino, Peter R., Schwartz, Peter E., and Santin, Alessandro D.

Published
2023
Full Text
View/download PDF

13. Trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody–drug conjugate with topoisomerase I inhibitor payload, shows antitumor activity in uterine and ovarian carcinosarcoma with HER2/neu expression

Author

Mauricio, Dennis, Bellone, Stefania, Mutlu, Levent, McNamara, Blair, Manavella, Diego D., Demirkiran, Cem, Verzosa, Miguel Skyler Z., Buza, Natalia, Hui, Pei, Hartwich, Tobias Max Philipp, Harold, Justin, Yang-Hartwich, Yang, Zipponi, Margherita, Altwerger, Gary, Ratner, Elena, Huang, Gloria S., Clark, Mitchell, Andikyan, Vaagn, Azodi, Masoud, Schwartz, Peter E., and Santin, Alessandro D.

Published
2023
Full Text
View/download PDF

14. Ovarian and uterine carcinosarcomas are sensitive in vitro and in vivo to elimusertib, a novel ataxia-telangiectasia and Rad3-related (ATR) kinase inhibitor

Author

Manavella, Diego D., McNamara, Blair, Harold, Justin, Bellone, Stefania, Hartwich, Tobias Max Philipp, Yang-Hartwich, Yang, Mutlu, Levent, Zipponi, Margherita, Demirkiran, Cem, Verzosa, Miguel Skyler, Altwerger, Gary, Ratner, Elena, Huang, Gloria S., Clark, Mitchell, Andikyan, Vaagn, Azodi, Masoud, Schwartz, Peter E., Dottino, Peter R., Choi, Jungmin, Alexandrov, Ludmil B., Buza, Natalia, Hui, Pei, and Santin, Alessandro D.

Published
2023
Full Text
View/download PDF

15. Elimusertib (BAY1895344), a novel ATR inhibitor, demonstrates in vivo activity in ATRX mutated models of uterine leiomyosarcoma

Author

Harold, Justin, Bellone, Stefania, Manavella, Diego D., Mutlu, Levent, McNamara, Blair, Hartwich, Tobias Max Philipp, Zipponi, Margherita, Yang-Hartwich, Yang, Demirkiran, Cem, Verzosa, Miguel Skyler, Choi, Jungmin, Dong, Weilai, Buza, Natalia, Hui, Pei, Altwerger, Gary, Huang, Gloria S., Andikyan, Vaagn, Clark, Mitchell, Ratner, Elena, Azodi, Masoud, Schwartz, Peter E., and Santin, Alessandro D.

Published
2023
Full Text
View/download PDF

16. Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer

Author

Roque, Dana M., Siegel, Eric R., Buza, Natalia, Bellone, Stefania, Silasi, Dan-Arin, Huang, Gloria S., Andikyan, Vaagn, Clark, Mitchell, Azodi, Masoud, Schwartz, Peter E., Rao, Gautam G., Reader, Jocelyn C., Hui, Pei, Tymon-Rosario, Joan R., Harold, Justin, Mauricio, Dennis, Zeybek, Burak, Menderes, Gulden, Altwerger, Gary, Ratner, Elena, and Santin, Alessandro D.

Published
2022
Full Text
View/download PDF

17. Synergistic activity of neratinib in combination with olaparib in uterine serous carcinoma overexpressing HER2/neu

Author

Yadav, Ghanshyam, Roque, Dana M., Bellone, Stefania, Manavella, Diego D., Hartwich, Tobias M.P., Zipponi, Margherita, Harold, Justin, Tymon-Rosario, Joan, Mutlu, Levent, Altwerger, Gary, Menderes, Gulden, Ratner, Elena, Buza, Natalia, Hui, Pei, Huang, Gloria S., Andikyan, Vaagn, Clark, Mitchell, Azodi, Masoud, Schwartz, Peter E., Alexandrov, Ludmil B., and Santin, Alessandro D.

Published
2022
Full Text
View/download PDF

18. Homologous recombination deficiency (HRD) signature-3 in ovarian and uterine carcinosarcomas correlates with preclinical sensitivity to Olaparib, a poly (adenosine diphosphate [ADP]- ribose) polymerase (PARP) inhibitor

Author

Tymon-Rosario, Joan R., Manara, Paola, Manavella, Diego D., Bellone, Stefania, Hartwich, Tobias Max Philipp, Harold, Justin, Yang-Hartwich, Yang, Zipponi, Margherita, Choi, Jungmin, Jeong, Kyungjo, Mutlu, Levent, Yang, Kevin, Altwerger, Gary, Menderes, Gulden, Ratner, Elena, Huang, Gloria S., Clark, Mitchell, Andikyan, Vaagn, Azodi, Masoud, Schwartz, Peter E., Alexandrov, Ludmil B., and Santin, Alessandro D.

Published
2022
Full Text
View/download PDF

19. Integrated mutational landscape analysis of uterine leiomyosarcomas

Author

Choi, Jungmin, Manzano, Aranzazu, Dong, Weilai, Bellone, Stefania, Bonazzoli, Elena, Zammataro, Luca, Yao, Xiaotong, Deshpande, Aditya, Zaidi, Samir, Guglielmi, Adele, Gnutti, Barbara, Nagarkatti, Nupur, Tymon-Rosario, Joan R., Harold, Justin, Mauricio, Dennis, Zeybek, Burak, Menderes, Gulden, Altwerger, Gary, Jeong, Kyungjo, Zhao, Siming, Buza, Natalia, Hui, Pei, Ravaggi, Antonella, Bignotti, Eliana, Romani, Chiara, Todeschini, Paola, Zanotti, Laura, Odicino, Franco, Pecorelli, Sergio, Ardighieri, Laura, Bilguvar, Kaya, Quick, Charles M., Silasi, Dan-Arin, Huang, Gloria S., Andikyan, Vaagn, Clark, Mitchell, Ratner, Elena, Azodi, Masoud, Imielinski, Marcin, Schwartz, Peter E., Alexandrov, Ludmil B., Lifton, Richard P., Schlessinger, Joseph, and Santin, Alessandro D.

Published
2021

22. DHES0815A, a novel antibody-drug conjugate targeting HER2/neu, is highly active against uterine serous carcinomas in vitro and in vivo

Author

Tymon-Rosario, Joan, Bonazzoli, Elena, Bellone, Stefania, Manzano, Aranzazu, Pelligra, Silvia, Guglielmi, Adele, Gnutti, Barbara, Nagarkatti, Nupur, Zeybek, Burak, Manara, Paola, Zammataro, Luca, Harold, Justin, Mauricio, Dennis, Buza, Natalia, Hui, Pei, Altwerger, Gary, Menderes, Gulden, Ratner, Elena, Clark, Mitchell, Andikyan, Vaagn, Huang, Gloria S., Silasi, Dan-Arin, Azodi, Masoud, Schwartz, Peter E., and Santin, Alessandro D.

Published
2021
Full Text
View/download PDF

28. Preclinical evaluation of avutometinib and defactinib in high‐grade endometrioid endometrial cancer.

Author

Hartwich, Tobias Max Philipp, Mansolf, Miranda, Demirkiran, Cem, Greenman, Michelle, Bellone, Stefania, McNamara, Blair, Nandi, Shuvro P., Alexandrov, Ludmil B., Yang‐Hartwich, Yang, Coma, Silvia, Pachter, Jonathan, and Santin, Alessandro D.

Subjects
FOCAL adhesion kinase, ENDOMETRIAL cancer, CELL lines, CELL cycle, CYTOTOXINS
Abstract

Background: High‐grade endometrial cancers (EAC) are aggressive tumors with a high risk of progression after treatment. As EAC may harbor mutations in the RAS/MAPK pathways, we evaluated the preclinical in vitro and in vivo efficacy of avutometinib, a RAF/MEK clamp, in combination with the focal adhesion kinase (FAK) inhibitors defactinib or VS‐4718, against multiple primary EAC cell lines and xenografts. Methods: Whole‐exome sequencing (WES) was used to evaluate the genetic landscape of five primary EAC cell lines. The in vitro activity of avutometinib and defactinib as single agents and in combination was evaluated using cell viability, cell cycle, and cytotoxicity assays. Mechanistic studies were performed using Western blot assays while in vivo experiments were completed in UTE10 engrafted mice treated with either vehicle, avutometinib, VS‐4718, or their combination through oral gavage. Results: WES results demonstrated multiple EAC cell lines to harbor genetic derangements in the RAS/MAPK pathway including KRAS/PTEN/PIK3CA/BRAF/ARID1A, potentially sensitizing to FAK and RAF/MEK inhibition. Five out of five of the EAC cell lines demonstrated in vitro sensitivity to FAK and/or RAF/MEK inhibition. By Western blot assays, exposure of EAC cell lines to defactinib, avutometinib, and their combination demonstrated decreased phosphorylated FAK (p‐FAK) as well as decreased p‐MEK and p‐ERK. In vivo the combination of avutometinib/VS‐4718 demonstrated superior tumor growth inhibition compared to single‐agent treatment and controls starting at Day 9 (p < 0.02 and p < 0.04) in UTE10 xenografts. Conclusions: Avutometinib, defactinib, and to a larger extent their combinations, demonstrated promising in vitro and in vivo activity against EAC cell lines and xenografts. These preclinical data support the potential clinical evaluation of this combination in high‐grade EAC patients. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

29. Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial

Author

Oaknin, Ana, Friedman, Claire F., Roman, Lynda D., D'Souza, Anishka, Brana, Irene, Bidard, François-Clement, Goldman, Jonathan, Alvarez, Edwin A., Boni, Valentina, ElNaggar, Adam C., Passalacqua, Rodolfo, Do, Khanh T.M., Santin, Alessandro D., Keyvanjah, Kiana, Xu, Feng, Eli, Lisa D., Lalani, Alshad S., Bryce, Richard P., Hyman, David M., Meric-Bernstam, Funda, Solit, David B., and Monk, Bradley J.

Published
2020
Full Text
View/download PDF

31. Derangements in HUWE1/c-MYC pathway confer sensitivity to the BET bromodomain inhibitor GS-626510 in uterine cervical carcinoma

Author

Bonazzoli, Elena, Bellone, Stefania, Zammataro, Luca, Gnutti, Barbara, Guglielmi, Adele, Pelligra, Silvia, Nagarkatti, Nupur, Manara, Paola, Tymon-Rosario, Joan, Zeybek, Burak, Altwerger, Gary, Menderes, Gulden, Han, Chanhee, Ratner, Elena, Silasi, Dan-Arin, Huang, Gloria S., Andikyan, Vaagn, Azodi, Masoud, Schwartz, Peter E., and Santin, Alessandro D.

Published
2020
Full Text
View/download PDF

33. Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy

Author

Zammataro, Luca, Lopez, Salvatore, Bellone, Stefania, Pettinella, Francesca, Bonazzoli, Elena, Perrone, Emanuele, Zhao, Siming, Menderes, Gulden, Altwerger, Gary, Han, Chanhee, Zeybek, Burak, Bianchi, Anna, Manzano, Aranzazu, Manara, Paola, Cocco, Emiliano, Buza, Natalia, Hui, Pei, Wong, Serena, Ravaggi, Antonella, Bignotti, Eliana, Romani, Chiara, Todeschini, Paola, Zanotti, Laura, Odicino, Franco, Pecorelli, Sergio, Donzelli, Carla, Ardighieri, Laura, Angioli, Roberto, Raspagliesi, Francesco, Scambia, Giovanni, Choi, Jungmin, Dong, Weilai, Bilguvar, Kaya, Alexandrov, Ludmil B., Silasi, Dan-Arin, Huang, Gloria S., Ratner, Elena, Azodi, Masoud, Schwartz, Peter E., Pirazzoli, Valentina, Stiegler, Amy L., Boggon, Titus J., Lifton, Richard P., Schlessinger, Joseph, and Santin, Alessandro D.

Published
2019

34. In vitro and in vivo activity of sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (Trop-2) in uterine serous carcinoma

Author

Han, Chanhee, Perrone, Emanuele, Zeybek, Burak, Bellone, Stefania, Tymon-Rosario, Joan, Altwerger, Gary, Menderes, Gulden, Feinberg, Jacqueline, Haines, Kaitlin, Muller Karger, Mariana Espinal, Bianchi, Anna, Zammataro, Luca, Manzano, Aranzazu, Bonazzoli, Elena, Manara, Paola, Buza, Natalia, Hui, Pei, Ratner, Elena, Silasi, Dan-Arin, Huang, Gloria S., Azodi, Masoud, Schwartz, Peter E., Lopez, Salvatore, and Santin, Alessandro D.

Published
2020
Full Text
View/download PDF

36. PARP-1 activity (PAR) determines the sensitivity of cervical cancer to olaparib

Author

Bianchi, Anna, Lopez, Salvatore, Altwerger, Gary, Bellone, Stefania, Bonazzoli, Elena, Zammataro, Luca, Manzano, Aranzazu, Manara, Paola, Perrone, Emanuele, Zeybek, Burak, Han, Chanhee, Menderes, Gulden, Ratner, Elena, Silasi, Dan-Arin, Huang, Gloria S., Azodi, Masoud, Newberg, Justin Y., Pavlick, Dean C., Elvin, Julia, Frampton, Garrett M., Schwartz, Peter E., and Santin, Alessandro D.

Published
2019
Full Text
View/download PDF

38. Lenvatinib Plus Pembrolizumab for Advanced Endometrial Cancer

Author

Makker, Vicky, Colombo, Nicoletta, Herráez, Antonio Casado, Santin, Alessandro D., Colomba, Emeline, Miller, David S., Fujiwara, Keiichi, Pignata, Sandro, Baron-Hay, Sally, Ray-Coquard, Isabelle, Shapira-Frommer, Ronnie, Ushijima, Kimio, Sakata, Jun, Yonemori, Kan, Kim, Yong Man, Guerra, Eva M., Sanli, Ulus A., McCormack, Mary M., Smith, Alan D., Keefe, Stephen, Bird, Steven, Dutta, Lea, Orlowski, Robert J., and Lorusso, Domenica

Published
2022
Full Text
View/download PDF

39. GOG 8020/210: Risk stratification of lymph node metastasis, disease progression and survival using single nucleotide polymorphisms in endometrial cancer: An NRG oncology/gynecologic oncology group study

Author

Brooks, Rebecca A., Tritchler, David S., Darcy, Kathleen M., Lankes, Heather A., Salani, Ritu, Sperduto, Paul, Guntupalli, Saketh, DiSilvestro, Paul, Kesterson, Joshua, Olawaiye, Alexander B., Moxley, Katherine, Waggoner, Steven, Santin, Alessandro, Rader, Janet S., Kizer, Nora T., Thaker, Premal H., Powell, Matthew A., Mutch, David G., Birrer, Michael J., and Goodfellow, Paul J.

Published
2019
Full Text
View/download PDF

40. PI3K oncogenic mutations mediate resistance to afatinib in HER2/neu overexpressing gynecological cancers

Author

Bonazzoli, Elena, Cocco, Emiliano, Lopez, Salvatore, Bellone, Stefania, Zammataro, Luca, Bianchi, Anna, Manzano, Aranzazu, Yadav, Ghanshyam, Manara, Paola, Perrone, Emanuele, Haines, Kaitlin, Espinal, Mariana, Dugan, Katherine, Menderes, Gulden, Altwerger, Gary, Han, Chanhee, Zeybek, Burak, Litkouhi, Babak, Ratner, Elena, Silasi, Dan-Arin, Huang, Gloria S., Azodi, Masoud, Schwartz, Peter E., and Santin, Alessandro D.

Published
2019
Full Text
View/download PDF

41. Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitor

Author

Li, Charles, Bonazzoli, Elena, Bellone, Stefania, Choi, Jungmin, Dong, Weilai, Menderes, Gulden, Altwerger, Gary, Han, Chanhee, Manzano, Aranzazu, Bianchi, Anna, Pettinella, Francesca, Manara, Paola, Lopez, Salvatore, Yadav, Ghanshyam, Riccio, Francesco, Zammataro, Luca, Zeybek, Burak, Yang-Hartwich, Yang, Buza, Natalia, Hui, Pei, Wong, Serena, Ravaggi, Antonella, Bignotti, Eliana, Romani, Chiara, Todeschini, Paola, Zanotti, Laura, Zizioli, Valentina, Odicino, Franco, Pecorelli, Sergio, Ardighieri, Laura, Silasi, Dan-Arin, Litkouhi, Babak, Ratner, Elena, Azodi, Masoud, Huang, Gloria S., Schwartz, Peter E., Lifton, Richard P., Schlessinger, Joseph, and Santin, Alessandro D.

Published
2019

42. A novel multiple biomarker panel for the early detection of high-grade serous ovarian carcinoma

Author

Han, Chanhee, Bellone, Stefania, Siegel, Eric R., Altwerger, Gary, Menderes, Gulden, Bonazzoli, Elena, Egawa-Takata, Tomomi, Pettinella, Francesca, Bianchi, Anna, Riccio, Francesco, Zammataro, Luca, Yadav, Ghanshyam, Marto, Jarrod A., Penet, Marie-France, Levine, Douglas A., Drapkin, Ronny, Patel, Abhijit, Litkouhi, Babak, Ratner, Elena, Silasi, Dan-Arin, Huang, Gloria S., Azodi, Masoud, Schwartz, Peter E., and Santin, Alessandro D.

Published
2018
Full Text
View/download PDF

45. Superior in vitro and in vivo activity of trastuzumab-emtansine (T-DM1) in comparison to trastuzumab, pertuzumab and their combination in epithelial ovarian carcinoma with high HER2/neu expression

Author

Menderes, Gulden, Bonazzoli, Elena, Bellone, Stefania, Altwerger, Gary, Black, Jonathan D., Dugan, Katherine, Pettinella, Francesca, Masserdotti, Alice, Riccio, Francesco, Bianchi, Anna, Zammataro, Luca, de Haydu, Christopher, Buza, Natalia, Hui, Pei, Wong, Serena, Huang, Gloria S., Litkouhi, Babak, Ratner, Elena, Silasi, Dan-Arin, Azodi, Masoud, Schwartz, Peter E., and Santin, Alessandro D.

Published
2017
Full Text
View/download PDF

46. SYD985, a novel duocarmycin-based HER2-targeting antibody-drug conjugate, shows promising antitumor activity in epithelial ovarian carcinoma with HER2/Neu expression

Author

Menderes, Gulden, Bonazzoli, Elena, Bellone, Stefania, Black, Jonathan, Altwerger, Gary, Masserdotti, Alice, Pettinella, Francesca, Zammataro, Luca, Buza, Natalia, Hui, Pei, Wong, Serena, Litkouhi, Babak, Ratner, Elena, Silasi, Dan-Arin, Huang, Gloria S., Azodi, Masoud, Schwartz, Peter E., and Santin, Alessandro D.

Published
2017
Full Text
View/download PDF

48. Polymerase ε (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro

Author

Bellone, Stefania, Bignotti, Eliana, Lonardi, Silvia, Ferrari, Francesca, Centritto, Floriana, Masserdotti, Alice, Pettinella, Francesca, Black, Jonathan, Menderes, Gulden, Altwerger, Gary, Hui, Pei, Lopez, Salvatore, de Haydu, Christopher, Bonazzoli, Elena, Predolini, Federica, Zammataro, Luca, Cocco, Emiliano, Ferrari, Federico, Ravaggi, Antonella, Romani, Chiara, Facchetti, Fabio, Sartori, Enrico, Odicino, Franco E., Silasi, Dan-Arin, Litkouhi, Babak, Ratner, Elena, Azodi, Masoud, Schwartz, Peter E., and Santin, Alessandro D.

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results